Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Minocycline in Carotid Revascularization
NCT02178813Phase 1Terminated
- Sponsor
- University of Pittsburgh
- Start
- Jul 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of minocycline in stroke, sponsored by University of Pittsburgh. Primary endpoint: Drug Safety/Tolerability. Started Jul 2014; status: terminated.
02
Drugs
minocycline
03
Conditions
stroke
Beyond the preview
Go deeper on NCT02178813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178813.